PATENT CLAIM ANALYSIS

Application Number: 15780398
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "275000"]

Abstract:
The disclosure includes a method of inducing direct reprogramming (transdifferentiation) into non-oncogenic cells accompanied by tumor cell apoptosis in human tumor cells using a small molecule composition, based on the mechanism of chemical-induction of direct cellular reprogramming. The disclosure also includes a small molecule composition used for the method, and culture media and agents prepared from the composition.

Claim (Index 2):
The composition of  claim 1 , wherein the composition comprises:\n A GSK3\u03b2 inhibitor present at a amount of 0.046-4.65 parts by weight or at a final concentration of 0.1-10 \u03bcM in a solution; and TGF\u03b2 inhibitor present at a amount of 0.038 -7.68 parts by weight or at a final concentration of 0.1-20 \u03bcM in a solution.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 93.0
- Lexical Diversity: 1.48837
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13697274', '15376536', '13704214', '15446552', '15072769']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7787100369771259
- 35 USC 102 Novelty (BERT): 0.5128413178570078
- Combined Prediction Score: 0.7521231650651141
- Mean Citation Score: 247.068706
- Max Citation Score: 257.53943
- Similarity Product: 162.73041922311722

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test